MedTrace Logo

Combined Amniotic Membrane and Platelet Rich Plasma Clot for Management of Central Corneal Perforation

NCT03500796 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-05-19

No results posted yet for this study

Summary

Use of amniotic membrane(AMT) and platelet rich plasma (PRP) clot for closure of central corneal perforation

Conditions

  • Corneal Perforation

Interventions

PROCEDURE

Platelet rich plasma clot implantation

Implantation of a platelet rich plasma clot, which is created from the plasma of the patients, and refrigerated to be inserted under the sealing amniotic membrane

PROCEDURE

Wound closure with amniotic membrane

Closure of the corneal perforation with a synthetic amniotic membrane with a 2 mm safety margin

Sponsors & Collaborators

  • Minia University

    lead OTHER

Principal Investigators

  • Ahmed A Abdelghany, MD · Assistant professor of Ophthalmology, Faculty of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-15
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03500796 on ClinicalTrials.gov